| Financial Year |
March 31 2023 |
| Monetary Funds |
12,192,178.12 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,744,540.57 |
| Accounts Receivable |
28,948,054.65 |
| Advances to Suppliers |
8,804,915.92 |
| Other Receivables |
21,051,207.37 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
173,002,708.11 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,748,741.47 |
| Total Current Assets |
254,261,404.96 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
33,028,418.78 |
| Investment Properties |
8,024,778.95 |
| Fixed Assetes |
138,116,338.40 |
| Under-construction Projects |
69,811,060.81 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
52,645,613.72 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
40,544,375.90 |
| Deferred Income Tax Assets |
35,102,460.07 |
| Other Non-Current Assets |
440,688.55 |
| Sub-Total of Non-Current Assets |
474,787,279.73 |
| Total Assets |
729,048,684.69 |
| Short-Term Loans |
45,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
37,980,089.73 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
8,953,095.91 |
| Taxes Payable |
2,395,251.72 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
23,744,243.53 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
16,100,619.93 |
| Other Current Liabilities |
4,088,183.41 |
| Sub-Total of Current Liabilities |
169,709,048.93 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
923,603.58 |
| Deferred Income Tax Liabilities |
963,081.75 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
93,028,732.10 |
| Total Liabilities |
262,737,781.03 |
| Paid-In Capital(Or Share Stock) |
262,752,000.00 |
| Capital Surplus |
334,699,653.36 |
| Surplus Reserve |
32,835,275.13 |
| LESS:Treasury Stock |
6,503,555.40 |
| Undistributed Profits |
-145,036,308.89 |
| Minority Stockholder's Interest |
-12,436,160.54 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
478,747,064.20 |
| Owner's Equity（Stockholder's Equity） |
466,310,903.66 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
729,048,684.69 |
